Ja. Wells, BINDING IN THE GROWTH-HORMONE RECEPTOR COMPLEX, Proceedings of the National Academy of Sciences of the United Statesof America, 93(1), 1996, pp. 1-6
Binding reactions between human growth hormone (hGH) and its receptor
provide a detailed account of how a polypeptide hormone activates its
receptor and more generally how proteins interact. Through high-resolu
tion structural and functional studies it is seen that hGH uses two di
fferent sites (site 1 and site 2) to bind two identical receptor molec
ules, This sequential dimerization reaction activates the receptor, pr
esumably by bringing the intracellular domains into close proximity so
they may activate cytosolic components. As a consequence of this mech
anism it is possible to build antagonists to the receptor by introduci
ng mutations in hGH that block binding at site 2 and to build even mor
e potent antagonists by combining these with mutants that enhance bind
ing at site 1. Alanine-scanning mutagenesis of all contact residues at
the site 1 interface shows that only a small and complementary set of
side chains clustered near the center of the interface affects bindin
g. The most important contacts are hydrophobic, and these are surround
ed by polar and charged interactions of lesser importance. Kinetic ana
lysis shows for the most part that the important side chains function
to maintain the complex, not to guide the hormone to the receptor, Hor
mone-induced homodimerization or heterodimerization reactions are turn
ing out to be pervasive mechanisms for signal transduction. Moreover,
the molecular recognition principles seen in the hGH-receptor complex
are likely to generalize to other protein-protein complexes.